Cosmos Health CEO forfeits warrants from Dec 2022 offering due to accounting concerns

Cosmos Health Inc.

CEO Grigorios Siokas forfeits warrants to purchase 260,870 shares to resolve executive compensation accounting issues.
Siokas retains the 260,870 shares purchased for $3M at $11.50/share in the December 2022 registered direct offering.
Amendment clarifies Siokas' allocation was determined after market close on December 19, 2022.
Independent board members approved the amendment to the Securities Purchase Agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.